Abstract
Several studies have documented that the perimenopausal transition in terms of menstrual period intervals and duration of bleeding is similar to that which is experienced at the onset of menarche in the adolescent. That is, the interval between menstrual periods begins to lengthen and the duration of bleeding remains unchanged. Current evidence suggests that, along with the lengthening of the interval between menstrual periods, the amount of flow with each menstrual period also changes (1–3). The amount of menstrual bleeding both increases and decreases in perimenopausal women. The percentage of perimenopausal women reporting a change in menstrual flow was 51% (n = 194) of 380 women (3). An increase in the amount of menstrual flow has been positively correlated with the irregular menses that occur in perimenopausal women (2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992;14:103–15.
Metcalf MG, Donald RA, Livesey JH. Classification of menstrual cycles in pre-and perimenopausal women. J Endocrinol 1981;91:1–10.
Burger HG, Dudley EC, Hopper JL, et al. The endocrinology of the menopause transition: a cross-sectional study of a population-based sample. J Clin Endocrinol 1995;80:3537–45.
Van Eijkeren MA, Christiaens GCML, Sikma JJ, Haspels AA. Menorrhagia: a review. Obstet Gynecol Surv 1989;44:421–9.
Cohen BJB, Gibor Y. Anemia and menstrual blood loss. Obstet Gynecol Surv 1980;35:597–618.
Fraser IS, Baird DT. Blood production and ovarian secretion rates of estradiol-1703B2 and estrone in women with dysfunctional uterine bleeding. J Clin Endocrinol Metab 1974;39:564–70.
Shaw RW. Assessment of medical treatments for menorrhagia. Br J Obstet Gynaecol 1994;101:15–18.
Smith SK, Abel MH, Kelly RW, Baird DT. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 1981;88:434–42.
Gleeson N, Devitt M, Sheppard BL, Bonnar J. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding. Br J Obstet Gynaecol 1993;100:768–71.
Santoro N, Brown JR, Adel T, Skurnick JH. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996; 81:1495–501.
Van Look PFA, Lothian H, Hunter WM, Michie EA, Baird DT. Hypothalamic-pituitary-ovarian function in perimenopausal women. Clin Endocrinol 1977;7:13–31.
Metcalf MG, Donald RA, Livesey JH. Pituitary-ovarian function in normal women during the menopausal transition. Clin Endocrinol 1981;14:245–55.
Critchley HOD, Abberton KM, Taylor NH, Healy DL. Endometrial sex steroid receptor expression in women with menorrhagia. Br J Obstet Gynaecol 1994; 101:428–34.
Carlson KJ, Nichols DH, Schiff I. Indications for hysterectomy. N Engl J Med 1993;328:856–60.
Lalonde A. Evaluation of surgical options in menorrhagia. Br J Obstet Gynaecol 1994;101:8–14.
Donnez J, Nisolle M, Clerck F, Casanas-Roux F, Saussoy P, Gillerot S. Advanced endoscopic techniques used in dysfunctional bleeding, fibroids and endometriosis, and the role of gonadotrophin-releasing hormone agonist treatment. Br J Obstet Gynaecol 1994;101:2–9.
Derman SG, Rehnstrom J, Neuwirth RS. The long-term effectiveness of hysteroscopic treatment of menorrhagia and leiomyomas. Obstet Gynecol 1991;77:591–6.
Nilsson L, Rybo G. Treatment of menorrhagia. Am J Obstet Gynecol 1971; 110:713–20.
Fraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust NZ J Obstet Gynecol 1991;31:66–70.
Preston JT, Cameron IT, Adams EJ, Smith SK. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Gynaecology 1993;102:401–8.
Cameron IT, Haining R, Lumsden M-A, Thomas VR, Smith SK. The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstet Gynecol 1990;76:85–8.
Fraser IS. Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progestogens. Aust NZ J Obstet Gynecol 1990;30:353–6.
Higham JM, Shaw RW. A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia. Am J Obstet Gynecol 1993;169:1134–9.
Chimbira TH, Anderson ABM, Naish C, Cope E, Turnbull AC. Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo. Br J Obstet Gynaecol 1980;87:1152–8.
Tang GWK, Lo SST. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability. Contraception 1995;51:231–5.
Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1990;97:690–4.
Milsom I, Andersson K, Andersch B, Rybo G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991; 164:879–83.
Bergquist A, Rybo G. Treatment of menorrhagia with intrauterine release of progesterone. Br J Obstet Gynaecol 1983;90:255–8.
Hahn L, Petruson B. The influence of acetylsalicylic acid and paracetomol on menstrual blood loss in women with and without an intrauterine contraceptive device. Am J Obstet Gynecol 1979;135:393–6.
Chamberlain G, Freeman R, Price F, Kennedy A, Green D, Eve L. A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. Br J Obstet Gynaecol 1991;98:707–11.
van Eijkeren MA, Christiaen GCML, Geuze HJ, Haspels AA, Sixma JJ. Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. Am J Obstet Gynecol 1992;166:1419–28.
Hall P, Maclachlan N, Thorn N, Nudo MWE, Taylor CG, Garrioch DB. Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid. Br J Obstet Gynaecol 1987;94:554–8.
Cameron IT, Leask R, Kelly RW, Baird DT. The effects of danazol, mefenamic acid, norethisterone, and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandin 1987;34:99–110.
Mäkäräinen L, Ylikorkala O. Primary and myoma associated menorrhagia: role of prostaglandin and effects of ibuprofen. Br J Obstet Gynaecol 1986:93:974–8.
Vercellini P, Crosignani PG. Goserelin (Zoladex) and the anaemic patient. Br J Obstet Gynaecol 1994;1001:33–7.
Petrucco OM, Fraser IS. The potential for the use of GnRH agonists for treatment of dysfunctional uterine bleeding. Br J Obstet Gynaecol 1992; 99:34–6.
Thomas EJ, Okuda KJ, Thomas NM. The combination of a depo-gonado-trophin releasing hormone agonist and cyclical hormone replacement therapy for dysfunctional uterine bleeding. Br J Obstet Gynaecol 1991;98:1155–9.
Carlson KJ, Miller BA, Fowler FJ. The Maine women’s health study: II. Outcome of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol 1994;83:566–72.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Archer, D.F. (1997). Medical Management of Menorrhagia in Pre- and Perimenopausal Women. In: Lobo, R.A. (eds) Perimenopause. Serono Symposia USA. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2288-0_21
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2288-0_21
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7488-9
Online ISBN: 978-1-4612-2288-0
eBook Packages: Springer Book Archive